Epidemiologic Burden of Skin Cancer in the US and Worldwide

AbstractPurpose of ReviewSkin cancer is one of the leading causes of skin disease burden worldwide. This systematic review provides an overview of the United States (US) and global melanoma and non-melanoma skin cancer (NMSC) epidemiologic studies published in the last 5  years.Recent FindingsThe incidence of melanoma and NMSC continues to rise both in the US and worldwide. The highest global age-standardized incidence rates (ASIRs) for melanoma were Australasia, North America, Eastern Europe, Western Europe, and Central Europe. Various results were reported for the mortality of skin cancer; however, overall, the mortality was higher in men than women and remained relatively stable. Notably, NMSC caused more deaths globally than melanoma, albeit at a slower rate.SummaryEpidemiologic studies on skin cancer provide the vital information needed to implement effective preventive efforts. Increased global skin cancer burden necessitates continued surveillance and production of accurate, high-quality NMSC and melanoma epidemiologic studies.
Source: Current Dermatology Reports - Category: Dermatology Source Type: research